Reproductive health care after transplantation

Krajewski, Colleen M.; Sucato, Gina S.

doi:10.1016/j.bpobgyn.2014.09.002

Cited by 22 publications

(27 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…29,30,32 As a result of human papilloma virus infections, the incidence of cervical, vaginal, vulvar, anal and oropharyn geal malignancies are increased in transplant recipi ents. 33,34 In addition, endometrial and ovarian cancers are also more common after organ transplantation, warrant ing regular gynaecological examinations in these individ uals. 33,34 Screening guidelines for the general population recommend a reduction of gynaecological examinations for lowrisk groups to every 3 or 5 years, but as transplant recipients are not considered lowrisk annual examina tions are advocated.…”

Section: Reviewsmentioning

confidence: 99%

“…33,34 In addition, endometrial and ovarian cancers are also more common after organ transplantation, warrant ing regular gynaecological examinations in these individ uals. 33,34 Screening guidelines for the general population recommend a reduction of gynaecological examinations for lowrisk groups to every 3 or 5 years, but as transplant recipients are not considered lowrisk annual examina tions are advocated. 33 To date, breast and prostate cancer have not been found to be more prevalent after liver trans plantation and general population s creening guidelines should be adhered to.…”

Section: Reviewsmentioning

confidence: 99%

“…33,34 Screening guidelines for the general population recommend a reduction of gynaecological examinations for lowrisk groups to every 3 or 5 years, but as transplant recipients are not considered lowrisk annual examina tions are advocated. 33 To date, breast and prostate cancer have not been found to be more prevalent after liver trans plantation and general population s creening guidelines should be adhered to. 35 Metabolic and cardiac disease Cardiovascular disease Cardiovascular disease is a leading cause of both mor bidity and mortality after liver transplantation.…”

Section: Reviewsmentioning

confidence: 99%

See 2 more Smart Citations

Keys to long-term care of the liver transplant recipient

Watt

2015

Nat Rev Gastroenterol Hepatol

View full text Add to dashboard Cite

Improvements in overall survival early after liver transplantation result in a growing number of patients with the potential for long-term survival. Data available on long-term survival, to date, reflect the situation of patients who received their liver transplant during a very different health-care era. Translating these data into the current medical era of liver transplantation is an important task, as a better understanding of aspects associated with morbidity and mortality is fundamental in improving the long-term outcome of liver transplant recipients. Malignancy screening, optimal treatment of recurrent disease and adequate management of metabolic disease are crucial contributions to advance patient care. In this Review, data specific to the liver transplant recipient will be evaluated and, in the absence of sufficient evidence at this time, recommendations and guidelines for the general population on management of long-term concerns will be assessed for their applicability after liver transplantation. In addition, other preventive strategies relating to pregnancy, contraception and vaccination are reviewed in detail.

show abstract

Section: Reviewsmentioning

confidence: 99%

Section: Reviewsmentioning

confidence: 99%

Section: Reviewsmentioning

confidence: 99%

See 1 more Smart Citation

Keys to long-term care of the liver transplant recipient

Watt

2015

Nat Rev Gastroenterol Hepatol

View full text Add to dashboard Cite

show abstract

“…The transdermal patch and vaginal ring circumvent the first-pass effect problem. A few studies have been done on patients with renal and liver transplants taking CHCs in the form of oral pills, patches, and vaginal rings; few adverse events, including rejection and graft failure, have been reported (Krajewski & Sucato, 2014). Reported adverse events include a patient who developed VTEs and another with deteriorated liver function (Krajewski & Sucato, 2014).…”

Section: Organ Transplantationmentioning

confidence: 96%

Practice Guideline: Contraception for Adolescents with Chronic Illness

Hall¹,

Rende²

2017

Journal of Pediatric Health Care

View full text Add to dashboard Cite

“…18 Oral contraceptives may be safely used in liver transplant recipients with good allograft function. 14,19 4. Correct Answers: B, C and E Hepatitis C virus core-antigen (HCV-Ag) may be an alternative for diagnosis of hepatitis C, and monitoring of therapy.…”

Section: Correct Answers: B and Cmentioning

confidence: 99%